Results 221 to 230 of about 64,832 (295)

STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian Patients. [PDF]

Cureus
Shukla P, Valame S, Nanda S, Shakya NK, Verma AK, Hanji A, Pednekar A, Bhagat S, Patil S, Petare AU, Bhushan S, Barkate H.   +11 more
europepmc   +1 more source

Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis. [PDF]

Front Pharmacol
Ning C, Yan Y, Wang Y, Li R, Liu W, Qiu L, Sun L, Yang Y.   +7 more
europepmc   +1 more source

Determination of the concentration of major active anti-emetic constituents within commercial ginger food products and dietary supplements [PDF]

, 2017
Isenring, Elisabeth A., Lohning, Anna E., Marx, Wolfgang   +2 more
core   +1 more source

Comprehensive gut microbiota and metabolomics combined with network pharmacology reveal the effects of acupuncture treatment for chemotherapy-induced nausea and vomiting. [PDF]

Transl Gastroenterol Hepatol
Wang X, Fan Y, Xiang Y, Zhang S, Yang Y.
europepmc   +1 more source

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [PDF]

, 2017
L. Zhang, Shun Lü, J. Feng, Arunee Dechaphunkul, J. Chang, D. Wang, Salvatore Chessari, Corinna Lanzarotti, Karin Jordan, Matti Aapro   +9 more
openalex   +1 more source

Reduction in nausea and vomiting in children undergoing cancer chemotherapy by either appropriate or sham auricular acupuncture points with standard care [PDF]

, 2012
Chiang, Yi Chien, Chien, Lung-Chang, Huang, Chen Kuan, Lin, Su Wen, Ren, Dianxu, Yeh, Chao Hsing   +5 more
core   +2 more sources

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types [PDF]

, 2017
Jeong Eun Kim, Joung-Soon Jang, Jae‐Weon Kim, Sung Yong Lee, Chi‐Heum Cho, Myung Ah Lee, Do-Jin Kim, Myung‐Ju Ahn, Kil Yeon Lee, Sun Jin Sym, Myong Choel Lim, Hun Jung, Cho Eun Kim, Kyung Wan Min   +13 more
openalex   +1 more source

Association of chemotherapy-induced nausea and vomiting or anorexia with plasma levels of five gastrointestinal peptides in patients receiving chemotherapy. [PDF]

J Pharm Health Care Sci
Tatsuta R, Tanaka R, Tashibu A, Suzuki Y, Suzuki K, Shibata T, Ando T, Shin T, Sato Y, Itoh H.   +9 more
europepmc   +1 more source

Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy

, 2012
Boccia, Clark, Howell
openalex   +2 more sources

Efficacy of NEPA for prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly emetogenic chemotherapy and usefulness of adding olanzapine for grade 2 or higher emesis. [PDF]

Medicine (Baltimore)
Na J, Kim JJ, Oh SB, Park K.
europepmc   +1 more source